Groton biotech firm working on much-needed drug to treat stroke, brain injuries
2 Dec 2021
Community Interest, Economic Development
A small drug development company that moved its headquarters from Cambridge, Mass., to the BioCT Innovations Commons on Shennecossett Road last year is aiming to have a huge impact on the treatment of strokes and brain injuries.
Co-founded by William Korinek of Stonington, who spent nearly a decade at Pfizer, Astrocyte Pharmaceuticals expects to launch a phase one clinical trial of its leading drug candidate in the first half of 2022. Last week, Astrocyte put out word that Stroke, a peer-reviewed journal, had published the results of preclinical studies of the drug, known for now as AST-004.
More Topics
A 400-foot barge built to help deliver Columbia-class ballistic missile submarines arrived Monday at Electric Boat, the prime contractor for the submarines.
The new Ocean Transport Barge Holland, constructed by Bollinger Shipyards of Lockport, La., was named after John Holland, the Irish-born immigrant who designed the first submarine purchased by...
A new proposal for the Five Corners area in the City of Groton, within walking distance of Electric Boat and Pfizer, calls for a mixed-use building with a New England-style façade and more commercial space on the first floor.
A developer, GBU Capital LLC. of Scottsdale, Ariz., has submitted a revised application for a mixed-use...
Groton has a new tool to go beyond the traditional public meeting.
The town started a new website, greatergroton.com, as a community engagement platform for town staff to post topics and projects and hear feedback from people who live, work or visit Groton.
People can register for the...
